Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis
about
CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanismsThe PD-1 pathway in tolerance and autoimmunityThe programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) miceAre Microglial Cells the Regulators of Lymphocyte Responses in the CNS?Programmed death-1/programmed death-L1 signaling pathway and its blockade in hepatitis C virus immunotherapyImmunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS SitesRole of the PD-1 pathway in the immune responseThe importance of mouse models to define immunovirologic determinants of progressive multifocal leukoencephalopathyRegulation of Neuroinflammation through Programed Death-1/Programed Death Ligand Signaling in Neurological DisordersOverlapping, additive and counterregulatory effects of type II and I interferons on myeloid dendritic cell functionsImmunoregulatory molecules are master regulators of inflammation during the immune responseCostimulatory molecule programmed death-1 in the cytotoxic response during chronic hepatitis CAnti-programmed death receptor 1 immunotherapy in melanoma: rationale, evidence and clinical potentialThe role of the PD-1 pathway in autoimmunity and peripheral toleranceVISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responsesBlockade of programmed death-1 in young (New Zealand Black x New Zealand White)F1 mice promotes the suppressive capacity of CD4+ regulatory T cells protecting from lupus-like diseasePD-1 regulates neural damage in oligodendroglia-induced inflammation.B7-H1-deficiency enhances the potential of tolerogenic dendritic cells by activating CD1d-restricted type II NKT cellsThe role of co-inhibitory signals in spontaneous tolerance of weakly mismatched transplantsYin-Yang of costimulation: crucial controls of immune tolerance and function.CNS expression of B7-H1 regulates pro-inflammatory cytokine production and alters severity of Theiler's virus-induced demyelinating disease.PD-1, gender, and autoimmunity.Programmed death 1 deficiency induces the polarization of macrophages/microglia to the M1 phenotype after spinal cord injury in mice.Target-dependent B7-H1 regulation contributes to clearance of central nervous system infection and dampens morbidity.Targeting immune co-stimulatory effects of PD-L1 and PD-L2 might represent an effective therapeutic strategy in stroke.GM-CSF-neuroantigen fusion proteins reverse experimental autoimmune encephalomyelitis and mediate tolerogenic activity in adjuvant-primed environments: association with inflammation-dependent, inhibitory antigen presentation.PD-L1 is increased in the spinal cord and infiltrating lymphocytes in experimental allergic encephalomyelitisImmunomodulation of antigen presenting cells promotes natural regulatory T cells that prevent autoimmune diabetes in NOD mice.CD8+ T lymphocytes control murine cytomegalovirus replication in the central nervous system of newborn animals.Programmed cell death 1 (PD-1) regulates the effector function of CD8 T cells via PD-L1 expressed on target keratinocytes.Nardilysin-dependent proteolysis of cell-associated VTCN1 (B7-H4) marks type 1 diabetes development.PD-L1(hi) retinal pigment epithelium (RPE) cells elicited by inflammatory cytokines induce regulatory activity in uveitogenic T cells.Disruption of the immune-checkpoint VISTA gene imparts a proinflammatory phenotype with predisposition to the development of autoimmunity.Proatherogenic immune responses are regulated by the PD-1/PD-L pathway in mice.No evidence of association between genetic variants of the PDCD1 ligands and SLE.Dendritic cell programming by cytomegalovirus stunts naive T cell responses via the PD-L1/PD-1 pathway.NFATc1 regulates PD-1 expression upon T cell activation.PD-1-dependent mechanisms maintain peripheral tolerance of donor-reactive CD8+ T cells to transplanted tissue.PDL1 is required for peripheral transplantation tolerance and protection from chronic allograft rejection.Multimodal coherent anti-Stokes Raman scattering microscopy reveals microglia-associated myelin and axonal dysfunction in multiple sclerosis-like lesions in mice
P2860
Q24534904-6AA7FB55-1411-4F76-8701-042CFDB7CC46Q24633549-04AE6891-0664-43AE-B40F-2602EF664612Q24670319-7B5ABFBA-C656-449B-8A60-79ECDBEAB050Q26774826-B799AAEC-0D92-4898-B50D-C193582BE78DQ26781481-B704157E-9E81-4D09-A6FE-148622D43F32Q26798402-7EF4E605-8C97-4B9F-96B8-2FA74102D4ABQ26828748-2CA77BF0-0040-4593-A58C-73E8C5DF20DEQ26859307-7357739F-60E9-4669-A547-7EB9CCB79192Q26997105-D3619E12-9286-47F1-8D61-0EFB1417F173Q27014714-F9DD1A3F-EECB-483F-8A0F-1538B579233DQ27022027-E02097F3-9C29-4E1B-A0EE-39CC7AFB3BA7Q27490355-1A29ACF5-2D02-41F1-87B6-7C7F2B79E5D5Q28084942-3226EC5D-7C54-41C3-86C4-BE81EFE7126FQ28304161-721C72E9-7926-4BA1-9B46-67F8955275F1Q28504888-428D451E-D0BB-4BD9-A0BE-F59738CB7607Q28590296-B23263B8-8AD7-421A-8151-797AB17FD6E1Q33406287-C5F3525C-91CF-4344-9AF3-C988E96406A2Q33592911-E2A7AF9F-C6B2-423E-A76F-A3BD7802D46BQ33648838-1C611175-F414-4984-A537-F7A2AA5F2649Q33872168-3630BA9F-4069-493B-8DB5-C864119E62A2Q33873566-4EB74025-329C-4D02-A28C-3DE9FA3B7AB9Q33910421-F3B55D32-FA8B-4D37-BC33-C896D51EBDA8Q34000753-A0300C8D-151F-4099-9F03-E1417C7E7FEBQ34018474-E0732E32-A57B-4BB6-804E-48CE3E720C02Q34024724-E305AF3A-894C-4B38-9D4F-5A931B694614Q34065039-8FC6C0BC-E2E1-4D0F-B2EF-E48425BE3DE1Q34094680-8F479DAF-99CC-4F07-A19D-23965CC9C60DQ34166274-83B0A426-BCEF-4028-9753-4CA54196AA13Q34166586-1FEAAABE-4462-4B69-8DF8-3288598DC2FFQ34173755-CA4D2888-C050-4418-A7A8-76E4F02F0FD0Q34227834-0EF25AAE-50D4-464F-B04F-22ABCE51959AQ34378721-14209B60-8FAA-4C4F-9E85-154DF62FC33FQ34384017-AC13C0BB-C86E-4389-94BD-DDD90351A409Q34582934-4F7FC0FE-630A-46AA-934A-414A53C6F016Q34585940-36F6280D-1B9F-49A5-B6EF-A9D51123C7ECQ34589567-AFD0C4FB-07D0-4428-84BC-B2F1DFB4AC8DQ34597324-FB65E823-D94D-4598-A394-E8D5F86A1A26Q34597955-17498A4A-2ACA-46C6-9987-19FEAD7FBEAFQ34697293-F50BD3D8-0920-4B52-90C4-8361E7CBACA9Q34700833-1D32DE54-54AB-4D4B-82EA-E7E2B7B89162
P2860
Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Critical role of the programme ...... l autoimmune encephalomyelitis
@ast
Critical role of the programme ...... l autoimmune encephalomyelitis
@en
Critical role of the programmed death-1
@nl
type
label
Critical role of the programme ...... l autoimmune encephalomyelitis
@ast
Critical role of the programme ...... l autoimmune encephalomyelitis
@en
Critical role of the programmed death-1
@nl
prefLabel
Critical role of the programme ...... l autoimmune encephalomyelitis
@ast
Critical role of the programme ...... l autoimmune encephalomyelitis
@en
Critical role of the programmed death-1
@nl
P2093
P2860
P356
P1476
Critical role of the programme ...... l autoimmune encephalomyelitis
@en
P2093
Alan D Salama
Fumihiko Tushima
Hideo Yagita
Hisaya Akiba
Jaime Imitola
Miyuki Azuma
Mohamed H Sayegh
Mohammed Javeed I Ansari
Samia J Khoury
P2860
P356
10.1084/JEM.20022119
P407
P577
2003-07-01T00:00:00Z